Block, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before March 18, 2025 to Discuss Your Rights – SQ

NEW YORK CITY, NY / ACCESS Newswire / January 24, 2025 / If you suffered a loss on your Block, Inc. (NYSE:SQ) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/block-inc-lawsuit-submission-form-2?prid=124937&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or […]

Contact Levi & Korsinsky by March 10, 2025 Deadline to Join Class Action Against BioAge Labs, Inc. (BIOA)

NEW YORK CITY, NY / ACCESS Newswire / January 24, 2025 / If you suffered a loss on your BioAge Labs, Inc. (NASDAQ:BIOA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/bioage-labs-inc-lawsuit-submission-form?prid=124936&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com

Class Action Filed Against Symbotic Inc. (SYM) Seeking Recovery for Investors – Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / January 24, 2025 / If you suffered a loss on your Symbotic Inc. (NASDAQ:SYM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/symbotic-lawsuit-submission-form-2?prid=124934&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Pacira BioSciences, Inc. Is Being Sued For Securities Law Violations And Affected Shareholders Are Urged To Contact The Schall Law Firm

LOS ANGELES, CA / ACCESS Newswire / January 24, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Pacira BioSciences, Inc. ("Pacira" or "the Company") (NASDAQ:PCRX) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder

InventHelp Inventor Develops New Eyewear Screen Protector (LOS-261)

“I wanted to create a simple and cost-effective way to prevent scratches on the lenses of various optical products,” said an inventor, fromSimi Valley, Calif., “so I invented the EYEWEAR SCREEN PROTECTOR. My design could extend the life of sunglasses, prescription glasses, and other eyewear.” https://mma.prnewswire.com/media/2099578/InventHelp_Logo_jpg_Logo.jpg The invention provides an effective way to protect the

Thurgood Marshall College Fund receives $25 million grant from Lilly Endowment for HBCU capacity building

Washington, D.C., Jan. 24, 2025 (GLOBE NEWSWIRE) — The Thurgood Marshall College Fund (TMCF) has received a substantial grant from Lilly Endowment Inc. to increase capacity at the organization and for the historically Black colleges and universities (HBCUs) that are its member schools. The $25 million grant will fund Project HBCU Capacity Building: Maximizing HBCU

Infrastructure Dividend Split Corp. Class A and Preferred Distributions

(TSX:IS.TO),(TSX:IS.PR.A),(TSX:IS.PR-A),(TSX:CLP.UN),(TSX:IS),(TSX:IS-PA), TORONTO, Jan. 24, 2025 (GLOBE NEWSWIRE) — Infrastructure Dividend Split Corp. (TSX: IS and IS.PR.A) (the “Fund”) is pleased to announce that a distribution for January 2025 will be payable to Class A shareholders as follows: Record Date Payable Date Distribution Per Equity Share January 31, 2025 February 14, 2025 $0.14 The Fund also

Elevar Therapeutics Presents Results from Post-Hoc Analysis of CARES-310 Study Evaluating the Impact of Viral and Non-Viral Etiology on Survival in Hepatocellular Carcinoma

Post-hoc analysis on survival outcomes for camrelizumab plus rivoceranib in patients with viral and non-viral hepatocellular carcinoma (HCC) demonstrated clinically meaningful overall survival and progression-free survival benefit for patients with hepatitis B or C viral infection HCC or non-viral HCC Results presented at ASCO GI January 24 showing favorable survival benefit of using camrelizumab plus

MicroCloud Hologram Inc. Explored the Combination of Detection Fields and Quantum Trajectories, Achieving In-depth Exploration and Accurate Measurement of Quantum Systems

MicroCloud Hologram Inc. (NASDAQ: HOLO), (“HOLO” or the “Company”), a technology service provider, their research on quantum systems has made significant breakthroughs, opening up new paths for in-depth exploration of quantum systems. The logical states of quantum bits and the values of physical interaction parameters are key issues in quantum system research. HOLO proposes studying

TransMedics Group (TMDX) Plunges Amidst Allegations of Fraud, Organ Trafficking – Hagens Berman

(NasdaqGM:TMDX), SAN FRANCISCO, Jan. 24, 2025 (GLOBE NEWSWIRE) — Shares of TransMedics, Group Inc. (NASDAQ: TMDX) suffered a sharp decline over the past two trading days following the release of a damaging report by activist short-seller Scorpion Capital. TransMedics' stock price has dropped $9.84, or 13%, since Scorpion released a report, titled “Walk Like An

Scroll to Top